SCHEMBL5027734

SCHEMBL5027734

CC(=O)C(c1ccccc1)(c1ccccc1)N1CCN(c2ccc(-c3ccccc3)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 5/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ CYP1A2 P05177 4/20 0.50
▸ HSD17B10 Q99714 3/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ ALOX12 P18054 1/20 0.50
▸ MEN1 O00255 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ SLC6A7 Q99884 2/20 0.48
▸ POLB P06746 1/20 0.48
▸ ME2 P23368 1/20 0.43
▸ ME1 P48163 1/20 0.43
▸ ME3 Q16798 1/20 0.43
▸ CYP3A4 P08684 4/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3864015 0.85 MEN1 (0.41) CYP2C9HPGDCYP2C19MAPK1MEN1
SCHEMBL3871229 0.82 MAPT (0.47) ALDH1A1HPGDMEN1KMT2AME2
SCHEMBL12273079 0.75 CTSL (0.46) USP2ALDH1A1CYP1A2HSD17B10CYP2C9
SCHEMBL5026280 0.75 HRH3 (0.44) ALDH1A1KMT2ACYP2D6
SCHEMBL3861148 0.73 DRD2 (0.54) —
SCHEMBL5026265 0.72 KMT2A (0.59) ALDH1A1CYP2C9HPGDMEN1KMT2A
Fluoride SCHEMBL27569822 0.72 MEN1 (0.56) USP2ALDH1A1CYP1A2HSD17B10CYP2C9
SCHEMBL5239356 0.72 MEN1 (0.68) USP2ALDH1A1CYP1A2HSD17B10CYP2C9
SCHEMBL3862213 0.70 KMT2A (0.52) MEN1KMT2APOLBGAA
SCHEMBL5017426 0.70 RAB9A (0.60) ALDH1A1CYP1A2HSD17B10CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871372-A1 COMBINATION THERAPY COMPRISING AN N-TYPE CALCIUM CHANNEL BLOCKER FOR THE ALLEVIATION OF PAIN Neuromed Pharmaceuticals, Ltd. (CA) 2008-01-02 — — EP disclosed
WO-2006105670-A1 COMBINATION THERAPY COMPRISING AN N-TYPE CALCIUM CHANNEL BLOCKER FOR THE ALLEVIATION OF PAIN NEUROMED PHARMACEUTICALS LTD. (CA) 2006-10-12 — — WO disclosed
Send feedback